VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $269,000 | -37.0% | 1,209 | -43.7% | 0.01% | -42.1% |
| Q1 2015 | $427,000 | +36.4% | 2,148 | -1.7% | 0.02% | +26.7% |
| Q4 2014 | $313,000 | +22.7% | 2,185 | +12.2% | 0.02% | +15.4% |
| Q3 2014 | $255,000 | -8.9% | 1,947 | -12.2% | 0.01% | -18.8% |
| Q2 2014 | $280,000 | -4.1% | 2,218 | 0.0% | 0.02% | -20.0% |
| Q1 2014 | $292,000 | -55.6% | 2,218 | -60.4% | 0.02% | -60.0% |
| Q4 2013 | $658,000 | +7.5% | 5,604 | +0.6% | 0.05% | -5.7% |
| Q3 2013 | $612,000 | +200.0% | 5,571 | +135.2% | 0.05% | +152.4% |
| Q2 2013 | $204,000 | – | 2,369 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |